7th Annual Peptides & Oligonucleotides Congress

Over 40 case studies, presentations and panel discussions focused on the key issues in peptide technologies, therapeutics case studies, discovery & development of oligonucleotide therapeutics, manufacturing and process development.

View Agenda: https://bit.ly/2PP4A5V

27 April 2019 – Day One (Kick-off Session)

• Turning Challenges to Successes in Peptides Delivery & Formulation

28 April 2020 – Day Two

• Peptide Design, Synthesis, Purification & Analytical Technologies
• Peptide Manufacturing & Process Development
• Oligonucleotide Synthesis, Chemistry, Formulation & Delivery, Process & Analytical Development

29 April 2020 – Day Three

• Peptide Therapeutics: Case Studies, Immunogenicity & Novel Disease Treatments
• Oligonucleotide Therapeutics & Manufacturing

2020 Live Webinar

Targeted, Controlled and Responsive Therapeutic Delivery through the Design of Self-Assembling Peptide Hydrogels

Presented by Aline Miller, Professor, University of Manchester

Register: https://bit.ly/2pzwpV9

• Design rules for engineering responsive peptide hydrogels
• Targeting endometriosis with sprayable peptide hydrogels
• Delivery of therapeutics to solid tumours
• Mucoadhesive hydrogels to prolong therapeutic efficacy

• Gene Liau, Executive Vice President and Head, Research & Preclinical Development, Stoke Therapeutics
• Ekkehard Leberer, Senior Director, Sanofi
• Matthew Catley, Research Director, MiNA Therapeutics
• Jennifer Franklin, Director, CMC Regulatory Affairs, IONIS Pharmaceuticals
• Michael Agrez, Chief Executive Officer, InterK Peptide Therapeutics
• David Earp, President and Chief Executive Officer, Circle Pharma
• Ali Tavassoli, Founder and Chief Scientific Officer, Curve Therapeutics
• Olivier Kitten, Founder and Chief Executive Officer, Affilogic
• Alex Batchelor, Chief Executive Officer, Orbit Discovery
• Els Beirnaert, Chief Executive Officer, Aelin Therapeutics
• Andrew Young, Chief Scientific Officer, Intarcia Therapeutics
• & many more